loading

Soleno Therapeutics Inc Azioni (SLNO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
32.66
- - - -
Cost Of Revenue
0.696
- - - -
Gross Profit
31.96
- - - -
Operating Expenses
14.34%
39.18
45.74 59.12 80.21 24.87
Benefits Costs and Expenses
6.61%
39.18
41.96 - - -
Costs And Expenses
14.34%
39.18
45.74 - - -
Depreciation and Amortization
0.40%
0.502
0.504 0.503 0.50 0.494
Operating Income/Loss
85.74%
-6.525
-45.74 -59.12 -80.21 -24.87
Nonoperating Income/Loss
7.77%
1.817
1.97 3.134 3.596 3.014
Income/Loss From Continuing Operations Before Tax
85.09%
-6.525
-43.77 -55.98 -76.62 -21.85
Income/Loss From Continuing Operations After Tax
89.24%
-4.708
-43.77 -55.98 -76.62 -21.85
Net Income/Loss
89.24%
-4.708
-43.77 -55.98 -76.62 -21.85
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
9.32%
50.48
46.18 1.2588 41.88 38.63
Diluted Average Shares
9.32%
50.48
46.18 1.2588 41.88 38.63
Basic Earnings Per Share
90.53%
-0.09
-0.95 -1.30 -1.83 -0.57
Diluted Earnings Per Share
90.53%
-0.09
-0.95 -1.30 -1.83 -0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):